Navigation Links
Waismann Method Survey Reveals Dependency Risk for People Using,Suboxone

BEVERLY HILLS, Calif.--(BUSINESS WIRE)--May 31, 2007 - The Waismann Method today announced findings from an online survey of Suboxone users, indicating that 66 percent of individuals currently taking Suboxone, also known as Subutex or Buprenorphine, believe they cannot stop taking the drug without assistance, indicating a physical dependency. Suboxone is often prescribed to treat dependency to opiates including OxyContin, Vicodin, Lortab or Fentanyl. Because Suboxone is 50 percent opiate in composition, it helps alleviate painful withdrawal symptoms caused by the original opiate, but still remains a replacement therapy that substitutes one opiate-based drug with another, according to Clare Waismann, addiction specialist for the Waismann Method.

"Patients are under the misconception that because this drug is prescribed by their doctors that it is a cure for their physical dependency to opiates," said Waismann. "Doctors need to be honest with their patients, letting them know that Suboxone will not eliminate their dependency to opiates and actually can be habit forming. In addition, regulation of drug marketing needs to be tougher, so that people know exactly what to expect."

Other key findings from the survey include:

-- Forty-seven percent of respondents said they weren't told by their doctors that they could develop a physical dependency to Suboxone

-- Fifty percent of respondents were told by their doctors that Suboxone is a cure for opiate dependency

-- Forty-nine percent said they have tried without success to stop taking Suboxone

-- Thirty-seven percent reported being addicted to OxyContin when they were prescribed Suboxone

"We are treating alarming numbers of people suffering dependencies to Suboxone, who assumed they were treating one dependency and ended up developing a new one," said Waismann. "Rather than write prescriptions, the addiction community should dir ect their efforts towards helping patients understand that relapse is not part of recovery. In addition, the antiquated notion that addiction is an incurable disease and belief that 'once an addict, always an addict,' needs to be dispelled. Patients are tired of being hostages of a belief that they must be eternally dependent on treatments and maintenance drugs. We must stop applying judgment, and start offering an effective solution that will keep them from returning to the treatment centers time after time."

To speak with Clare Waismann or a former Suboxone user, please contact Katie Williams at 619-234-0345 or Williams@formulapr.com.

For more information about the Waismann Method, visit www.opiates.com. To schedule an interview please contact Katie Williams at 619-234-0345 or Williams@formulapr.com.

About the Waismann Method

Drs. Clifford A. Bernstein is the medical director of Anesthesia Assisted Medical Opiate Detoxification Inc. (A.A.M.O.D.). A.A.M.O.D. uses the exclusive Waismann Method of Neuro-Regulation to treat opiate dependency. Performed in a hospital intensive care unit, the Waismann Method involves cleansing opiate receptors in a patient's brain of the narcotics while the patient is under anesthesia, reversing the chemical imbalance. During the procedure, the patient will experience minimal conscious withdrawal, and will be able to return home within days. Over 65 percent of the patients who are treated with the Waismann Method remain drug free after one year. The Waismann Foundation, founded by Clare Waismann, is headquartered in Beverly Hills, Calif.

Contact

Formula
Katie Williams, 619-234-0345
Williams@formulapr.com


'"/>




Related medicine technology :

1. Waismann Method Survey Reveals 65 Percent of Women Seeking Opiate Dependency Treatment Are Mothers
2. New Point-of-Care Methods to Measure Coronary and Cerebrovascular Risk
3. Researchers Discover Method for Identifying How Cancer Evades the Immune System
4. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
5. In New Study, Duloxetine Was Equally Effective, Regardless of Switch Method, in Reducing Painful Symptoms in Ssri Non- or Partial-responders with Depression
6. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
7. Women Well-Informed About Breast Cancer, Yet Lacking Knowledge About Current Treatments, New Survey Finds
8. Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist
9. Survey: Migraine Patients Taking Potentially Addictive Barbiturate or Opioid Medications Not Approved by FDA as Migraine Treatments
10. New Survey Finds Troubling Data on American Asthma Sufferers
11. Survey Reveals Significant Public Lack of Diabetes Awareness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... April 20, 2017 Research and ... Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through ... their offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming Production ... an in-depth assessment of the current trends in the ...
(Date:4/20/2017)... , April 20, 2017   ZappRx, Inc ., ... specialty drug prescribing process, today announced it closed $25 million ... a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included participation ... round in 2014, and GV (formerly Google Ventures). ...
(Date:4/20/2017)... NeuroVive Pharmaceutical AB (Nasdaq Stockholm: ... preclinical results demonstrating anti-fibrotic effects with NV556, ... (NASH), in an additional well-validated experimental NASH ... previously shown similar anti-fibrotic effects in the ... present novel data demonstrating anti-fibrotic effects of ...
Breaking Medicine Technology:
(Date:4/21/2017)... ... ... The Patient Advocacy Community of The Beryl Institute presented Eve DeVaro, Director, Patient ... Award in recognition of her extraordinary contributions to the field of patient advocacy ... Institute’s annual Patient Experience Conference on March 20 in Denver, Colorado. ...
(Date:4/21/2017)... Hong Kong (PRWEB) , ... April 21, 2017 , ... ... Printing (U3DP), the first 3D printing facility among higher education institutions in Hong Kong ... 3D printing, in terms of the range and quantity of facilities in Hong Kong. ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... AWARE: A Week of Addiction and Recovery Education, from April 24 to April ... preventing substance use disorders. , The mission of AWARE is to instill ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... announced an exciting new partnership with the highly regarded and well renowned Asian ... highly innovative, myTAP & myTAP PAP Nasal Pillow Mask, and will stabilize and ...
(Date:4/21/2017)... Worcestershire, UK (PRWEB) , ... April 21, 2017 ... ... Award for Enterprise in the category of International Trade, the UK’s most prestigious ... in international trade, which represents 95% of total revenues and has grown by ...
Breaking Medicine News(10 mins):